Using ex vivo organotypic cultures to investigate donor cell integration in the gut
使用离体器官型培养物研究肠道中供体细胞的整合
基本信息
- 批准号:NC/V001078/1
- 负责人:
- 金额:$ 39.31万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The correct functioning of the gut depends on the movement of the gut wall along the length of the bowel. This functional movement is coordinated by nerve cells within the gut called the enteric nervous system, or ENS for short. When there is an issue with any of these nerve cells this results in diseases called "enteric neuropathies". There are no cures for these diseases and successful treatment remains a challenge. Unfortunately, patients often have surgery to remove large pieces of gut. This can cause significant problems, as patients have to live with long-term, life changing symptoms. Therefore, new treatments for these diseases are vital.Over the past 10 years scientists have suggested that stem cells may be a good option to treat these diseases. Work from our group, and others, have shown that it is possible to rescue nerve cells in mice by transplanting gut nervous system stem cells. However, we don't really understand how these stem cells do this. One important factor is that most of these studies have performed surgery in mice and transplanted donor cells to the gut. While this has worked in showing donor stem cells can grow and function in the gut, there are a number of drawbacks. Normally, these studies use a large number of mice as it is only possible to transplant cells once. After the surgery it is also difficult to understand how the donor cells behave as it is difficult to see them inside the mouse. Recently, our group have developed a method which allows us to take some mouse gut and keep this alive in a dish for up to 3 weeks. This system allows us to get 6 segments of bowel from any 1 mouse gut. By doing this we can reduce the number of mice used in any experiment by nearly 84%. Also using this approach we don't have to do surgery on the mice anymore. As we can then grow the gut in an incubator we can transplant any cells and learn how they behave in the gut more easily. Therefore, in this study we hope to:1) Investigate how different gut nervous system stem cells move in the gut2) Determine what happens to the gut after transplantation3) Assess how gut nervous system stem cells function after transplantation.To do this, we want to use our new method to investigate how different gut nervous system stem cells behave in the gut after transplantation, while reducing the numbers of mice used. To investigate how different gut nervous system stem cells move in the gut we will first tag mouse embryonic stem cells with a marker. This marker will allow us to follow the cells after transplantation. With help from colleagues in the University of Sheffield we will then make gut nervous system stem cells which contain the marker in a dish. We will then transplant these gut nervous system stem cells to mouse gut using our new system and look at what they do over 3 weeks. We will then study how transplantation affects the gut by looking at the protein code of the gut before and after we transplant donor cells. Finally, we will look at how the donor cells work in the gut by applying a dye which allows us to record activity in individual cells. These studies will allow us to understand how different gut nervous system stem cells behave in the gut after transplantation, and what this does to the gut itself. This will be very important in helping to develop better treatments for gut diseases. However, these studies will also help to prove that our new system really works and that we can reduce the number of animals used in these types of experiment. By showing this we hope that we can encourage other scientists to use this system so that we can help to reduce the overall number of animals used in research.
肠道的正常功能取决于肠壁沿肠道长度的移动。这种功能性运动是由肠道内的神经细胞协调的,称为肠道神经系统,或简称ENS。当这些神经细胞中的任何一个出现问题时,就会导致称为“肠道神经病”的疾病。这些疾病没有治愈的方法,成功的治疗仍然是一个挑战。不幸的是,患者经常需要手术切除大块的肠道。这可能会导致严重的问题,因为患者不得不生活在长期的、改变生活的症状中。因此,治疗这些疾病的新疗法是至关重要的。在过去的10年里,科学家们建议干细胞可能是治疗这些疾病的一个很好的选择。我们团队和其他人的工作表明,通过移植肠道神经系统干细胞来拯救小鼠的神经细胞是可能的。然而,我们并不真正了解这些干细胞是如何做到这一点的。一个重要的因素是,这些研究中的大多数都在小鼠身上进行了手术,并将供体细胞移植到肠道中。虽然这在证明捐赠者干细胞可以在肠道中生长和发挥作用方面起到了作用,但也存在一些缺陷。通常,这些研究使用大量的小鼠,因为只可能移植一次细胞。手术后,也很难理解捐赠者细胞的行为,因为很难在老鼠体内看到它们。最近,我们团队开发了一种方法,可以让我们提取一些老鼠的内脏,并将其放在培养皿中保存长达3周。这个系统允许我们从任何一只小鼠的肠道中获得6个肠段。通过这样做,我们可以将任何实验中使用的小鼠数量减少近84%。同样,使用这种方法,我们不再需要对小鼠进行手术。因为我们可以在孵化器中培养肠道,所以我们可以移植任何细胞,并更容易地了解它们在肠道中的行为。因此,在这项研究中,我们希望:1)研究不同的肠道神经系统干细胞如何在肠道中移动2)确定移植后肠道的变化3)评估肠道神经系统干细胞在移植后的功能。为此,我们希望使用我们的新方法来研究不同的肠道神经系统干细胞在移植后在肠道中的表现,同时减少使用的小鼠数量。为了研究不同的肠道神经系统干细胞如何在肠道内移动,我们将首先用一个标记标记小鼠胚胎干细胞。这个标记物将允许我们在移植后跟踪细胞。在谢菲尔德大学同事的帮助下,我们将制造肠道神经系统干细胞,这种干细胞在培养皿中含有这种标记。然后,我们将使用我们的新系统将这些肠道神经系统干细胞移植到小鼠的肠道中,并观察它们在3周内的表现。然后,我们将通过观察移植供体细胞前后肠道的蛋白质编码来研究移植对肠道的影响。最后,我们将通过应用一种染料来观察供体细胞在肠道中的工作方式,这种染料允许我们记录单个细胞的活动。这些研究将使我们能够了解不同的肠道神经系统干细胞在移植后在肠道中的表现,以及这对肠道本身的影响。这在帮助开发更好的肠道疾病治疗方法方面将非常重要。然而,这些研究也将有助于证明我们的新系统确实有效,我们可以减少在这些类型的实验中使用的动物数量。通过展示这一点,我们希望我们可以鼓励其他科学家使用这个系统,这样我们就可以帮助减少研究中使用的动物总数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Conor McCann其他文献
138 - Baseline cardiovascular disease and risk of cardiac events following radical radiotherapy in NSCLC
138 - 非小细胞肺癌根治性放疗后基线心血管疾病与心脏事件风险
- DOI:
10.1016/s0169-5002(23)00565-2 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:4.400
- 作者:
Gerard Walls;David Johnston;Mark Harbinson;Conor McCann;Peter McKavanagh;Jayaraj Erekkath;Conor McGarry;Suneil Jain;Aidan Cole;Cathryn Crockett;Jonathan McAleese;Gerard Hanna - 通讯作者:
Gerard Hanna
Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study
- DOI:
10.1016/j.radonc.2023.109762 - 发表时间:
2023-09-01 - 期刊:
- 影响因子:
- 作者:
Gerard M. Walls;John O'Connor;Mark Harbinson;Eamon P. McCarron;Frances Duane;Conor McCann;Peter McKavanagh;David I. Johnston;Jayaraj Erekkath;Valentina Giacometti;Anna T. Gavin;Jonathan McAleese;Alan R. Hounsell;Aidan J. Cole;Karl T. Butterworth;Conor K. McGarry;Gerard G. Hanna;Suneil Jain - 通讯作者:
Suneil Jain
Baseline Cardiac Parameters as Biomarkers of Radiation Cardiotoxicity in Lung Cancer
基线心脏参数作为肺癌放射性心脏毒性的生物标志物
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
G. M. Walls;Nicola Hill;Michael McMahon;Brian óg Kearney;Conor McCann;P. McKavanagh;V. Giacometti;A. J. Cole;Suneil Jain;Conor K. McGarry;Karl Butterworth;J. McAleese;M. Harbinson;Gerard G Hanna - 通讯作者:
Gerard G Hanna
Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis
- DOI:
10.1016/j.radonc.2024.110085 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:
- 作者:
Gerard M. Walls;Conor McCann;John O'Connor;Anna O'Sullivan;David I. Johnston;Jonathan McAleese;Conor K. McGarry;Aidan J. Cole;Suneil Jain;Karl T. Butterworth;Gerard G. Hanna - 通讯作者:
Gerard G. Hanna
138 - Baseline cardiovascular disease and risk of cardiac events following radical radiotherapy in NSCLC
138 - 非小细胞肺癌根治性放疗后基线心血管疾病与心脏事件风险
- DOI:
10.1016/s0169-5002(23)00565-2 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:4.400
- 作者:
Gerard Walls;David Johnston;Mark Harbinson;Conor McCann;Peter McKavanagh;Jayaraj Erekkath;Conor McGarry;Suneil Jain;Aidan Cole;Cathryn Crockett;Jonathan McAleese;Gerard Hanna - 通讯作者:
Gerard Hanna
Conor McCann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
ColQ基因新突变合并反式EX14-EX15缺失对先天性肌无力5型的致病作用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
HucMSC-Ex调控巨噬细胞FXR表达抑制铁死亡修复IBD的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
Sirt1 抑制剂 EX527 在 HBV 相关肝癌脂质代谢重编程中的作用及临床意义
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
基于抗菌/消炎/免疫调节研究MDC@Ex-γ3-CeO2@PDA多靶点阻断和协同干预脓毒症急性肺损伤的作用及机制
- 批准号:82372161
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
EX-4/SDF-1/PLGA复合静电纺丝纤维膜对牙周原位组织再生的协同作用及机制研究
- 批准号:82360193
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于IL-23-JAK2/STAT3信号轴探讨鼻敏康合剂调节ex-ILC2/ILC3抑制变应性鼻炎最轻持续性炎症的机制
- 批准号:82305327
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ex vivo模型联合多组学手段绘制胃癌曲妥珠单抗继发耐药机制并探索克服耐药策略
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
以EX1和EX2为靶标的stargazin和AMPA受体相互作用研究
- 批准号:81872848
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
基于T2ex原理的新型镧系金属造影剂的设计及应用
- 批准号:21801235
- 批准年份:2018
- 资助金额:27.5 万元
- 项目类别:青年科学基金项目
磷酸化和可变剪切修饰影响Bnip3调控线粒体自噬和细胞凋亡的结构及功能研究
- 批准号:31670742
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
- 批准号:
23K08226 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Boron delivery to brain tumor using cerebrospinal fluid circulation with ex-vivo microimaging of boron drugs for BNCT
利用脑脊液循环将硼输送至脑肿瘤,并通过硼药物的体外显微成像进行 BNCT
- 批准号:
23K14383 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Using transcriptomics and ex vivo organotypic models to discover mechanisms of APOL1-associated podocytopathies
使用转录组学和离体器官型模型来发现 APOL1 相关足细胞病的机制
- 批准号:
10590895 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models
使用离体和体外实验模型对新型抗疱疹病毒药物阿美那韦和普替利韦进行人胎盘生物处置
- 批准号:
10682469 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
使用离体、体内模型和患者突变来探究胰腺外分泌-内分泌串扰
- 批准号:
10706558 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
使用离体、体内模型和患者突变来探究胰腺外分泌-内分泌串扰
- 批准号:
10594228 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Ex vivo generation of tumor-reactive T cells for adoptive cell transfer using an immune enhanced, patient derived tumor organoid-on-a-chip (iTOC)
使用免疫增强的、患者来源的肿瘤类器官芯片 (iTOC) 体外生成肿瘤反应性 T 细胞,用于过继细胞转移
- 批准号:
10571848 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Making donated lungs infected with cytomegalovirus safer: nanoparticle-mediated deletion of essential viral genes prior to transplant using ex vivo lung perfusion
使感染巨细胞病毒的捐赠肺更安全:使用离体肺灌注在移植前通过纳米颗粒介导删除必需病毒基因
- 批准号:
465080 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Operating Grants
Advanced Artificial Intelligence for Human Ex Vivo Lung Perfusion using Digital Twins
使用数字孪生进行人类离体肺灌注的先进人工智能
- 批准号:
469918 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
Operating Grants
AI-assisted Imaging and Prediction of Cardiac Arrhythmia Origins using 4D Ultrasound
使用 4D 超声进行人工智能辅助成像和心律失常起源预测
- 批准号:
10473146 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别: